Skip to main content
Clinical Trials/ACTRN12623000052639
ACTRN12623000052639
Recruiting
未知

Investigating the effect of multidisciplinary prehabilitation on deconditioning, hospital acquired complications and length of stay in patients offered Haematopoietic allogenic stem cell transplant: A feasibility trial.

RAH Haematology Clinical Trials & Cancer Haematology0 sites20 target enrollmentJanuary 17, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Acute myeloid leukaemia
Sponsor
RAH Haematology Clinical Trials & Cancer Haematology
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 17, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
RAH Haematology Clinical Trials & Cancer Haematology

Eligibility Criteria

Inclusion Criteria

  • Participants must be aged 18 years of age or older.
  • Diagnosed with Acute myeloid leukemia (AML)/Myelodysplastic Syndrome (MDS) and offered allo\-HSCT at the RAH.
  • Medically stable (as determined by absolute contraindications to exercise as per national and international exercise guidelines (Exercise and Sports Science Australia, American College of Sports Medicine)) and have written clearance from their consultant haematologist.

Exclusion Criteria

  • Cognitive impairment severe enough to limit participation in the prehab program (as determined by a medical practitioner).
  • Any absolute contraindications to exercise (as per written medical clearance), for example unstable angina or uncontrolled heart failure. Patients with permanent pacemaker will be excluded from bio\-electrical impedance spectroscopy.

Outcomes

Primary Outcomes

Not specified

Similar Trials